---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-028770"
form_type: "8-K"
ticker: "ASBP"
cik: "0001847345"
company_name: "Aspire Biopharma Holdings, Inc."
filed_at: "2024-07-23T23:59:59+00:00"
generated_at: "2026-05-31T18:11:14.397661+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# PowerUp Acquisition terminates merger with Visiox Pharmaceuticals on July 19

## Summary
- Terminated Merger Agreement with Visiox Pharmaceuticals due to failure to satisfy closing conditions by June 30, 2024.
- Company intends to continue evaluating other business combination targets but provides no assurance.
- Termination effective July 19, 2024; no transaction resulted.
- No financial terms of the abandoned merger were disclosed in the filing.

## SEC filing metadata
- accession: 0001493152-24-028770
- form_type: 8-K
- ticker: ASBP
- cik: 0001847345
- company_name: Aspire Biopharma Holdings, Inc.
- filed_at: 2024-07-23T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1847345/000149315224028770/0001493152-24-028770-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1847345/000149315224028770/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-028770
- JSON: https://secwatch.observer/filing/0001493152-24-028770.json
- Plain text: https://secwatch.observer/filing/0001493152-24-028770.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.